You are subscribed to What's New at CBER for U.S. Food & Drug Administration (FDA).
This page has been updated recently.
December 19, 2014 Approval Letter - cobas TaqScreen MPX Test, version 2.0 for use with the cobas s 201 system
Posted: 12/22/2014
Minimal Manipulation of Human Cells, Tissues, and Cellular and Tissue-Based Products: Draft Guidance for Industry and Food and Drug Administration Staff
Posted: 12/22/2014
December 10, 2014 Summary Basis for Regulatory Action - Fluzone Intradermal Quadrivalent (PDF - 144KB)
Posted: 12/22/2014
| This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 |  |
